Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:43 PM
Ignite Modification Date:
2025-12-24 @ 10:43 PM
NCT ID:
NCT03750435
Eligibility Criteria:
Inclusion Criteria:
* Any type of atrial fibrillation or left atrial tachycardia
* Able to give written informed consent
* Age \>18 years old and ≤ 80 years
* Fulfill established clinical criteria for catheter ablation of atrial fibrillation (1)
* No evidence of significant structural heart disease or congenital heart disease
Exclusion Criteria:
Intolerance or unwillingness to oral anticoagulation with Warfarin
* Bleeding disorder
* Contraindication to CT scan
* Presence of intracardiac thrombus
* Vascular disorder preventing access to femoral veins
* Cardiac congenital abnormality
* Severe, life threatening non-cardiac disease
* Active malignant disease and recent (\<5 years) malignant disease
* Presence of ASD or PFO closure device
* Unable or unwilling to comply with F/U requirements
* Renal impairment
* Pregnancy
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
80 Years
Study:
NCT03750435
Study Brief:
Protocol Section:
NCT03750435